-10.90 (-0.92%) Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Alvotech and Dr. Reddy’s enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) for global markets.’
The above information is a part of company’s filings submitted to BSE.